| 1.9 |
11.6 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.6 |
6.3 |
GO:0042361 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.3 |
4.0 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 1.3 |
5.1 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 1.2 |
4.6 |
GO:0032597 |
B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 1.1 |
3.4 |
GO:2000309 |
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 1.0 |
8.7 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.8 |
3.3 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.8 |
2.3 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.7 |
3.4 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.6 |
1.9 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.6 |
3.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.5 |
3.1 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.5 |
2.0 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.5 |
2.8 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.5 |
0.5 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.5 |
1.4 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.4 |
2.1 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.4 |
0.4 |
GO:0086068 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.4 |
1.3 |
GO:0001794 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.4 |
1.6 |
GO:1900138 |
negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.4 |
1.6 |
GO:2000173 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.4 |
1.2 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.4 |
1.2 |
GO:0002582 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.4 |
1.6 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.4 |
0.8 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.4 |
1.2 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.4 |
2.3 |
GO:0070778 |
L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.4 |
2.7 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.4 |
1.9 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.4 |
0.8 |
GO:0010645 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.4 |
0.4 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.4 |
0.4 |
GO:0016107 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 0.4 |
1.1 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.4 |
1.1 |
GO:0051040 |
regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.4 |
1.1 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 |
1.4 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.3 |
1.0 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.3 |
1.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.3 |
9.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.3 |
3.0 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 0.3 |
2.0 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 0.3 |
2.9 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 |
1.6 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.3 |
1.3 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.3 |
1.2 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.3 |
0.9 |
GO:0048560 |
establishment of anatomical structure orientation(GO:0048560) |
| 0.3 |
2.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 |
0.3 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.3 |
0.6 |
GO:0060557 |
positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.3 |
1.5 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.3 |
2.7 |
GO:0051121 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.3 |
1.8 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.3 |
0.3 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.3 |
0.8 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.3 |
0.8 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
0.8 |
GO:0051714 |
positive regulation of cytolysis in other organism(GO:0051714) |
| 0.3 |
1.1 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.3 |
0.6 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.3 |
1.9 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.3 |
1.4 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.3 |
1.6 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 |
3.0 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 |
0.8 |
GO:1902948 |
regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.3 |
1.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 |
0.8 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.3 |
2.1 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.3 |
1.6 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.3 |
0.8 |
GO:0070650 |
endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.3 |
0.8 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.3 |
0.8 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.3 |
0.8 |
GO:0048867 |
stem cell fate determination(GO:0048867) |
| 0.3 |
1.0 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
2.0 |
GO:0061709 |
reticulophagy(GO:0061709) |
| 0.3 |
2.0 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.2 |
0.7 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.2 |
0.7 |
GO:1903937 |
response to acrylamide(GO:1903937) |
| 0.2 |
1.5 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.2 |
0.2 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 0.2 |
0.2 |
GO:0032827 |
natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.2 |
1.2 |
GO:0009137 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 |
1.2 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 |
0.7 |
GO:0046379 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 |
0.7 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.2 |
1.0 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 |
0.7 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.2 |
1.2 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.2 |
2.8 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 |
0.7 |
GO:0051596 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 |
1.2 |
GO:1903750 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.2 |
0.9 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.2 |
0.9 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.2 |
0.7 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
0.4 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.2 |
0.7 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.2 |
1.1 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 |
0.7 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
0.4 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.2 |
0.6 |
GO:0070429 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
| 0.2 |
0.2 |
GO:0032222 |
regulation of synaptic transmission, cholinergic(GO:0032222) |
| 0.2 |
0.6 |
GO:1990922 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.2 |
0.8 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.2 |
0.6 |
GO:0050976 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.2 |
0.6 |
GO:0002884 |
negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
| 0.2 |
2.9 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.2 |
1.2 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.2 |
1.6 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.2 |
2.4 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 |
0.8 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.2 |
0.6 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.2 |
0.6 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 |
0.6 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.2 |
0.2 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.2 |
0.6 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.2 |
1.7 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.2 |
0.2 |
GO:0010875 |
positive regulation of cholesterol efflux(GO:0010875) |
| 0.2 |
0.6 |
GO:0071676 |
negative regulation of mononuclear cell migration(GO:0071676) |
| 0.2 |
0.6 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.2 |
2.7 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
1.1 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.2 |
0.8 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.2 |
0.7 |
GO:0060529 |
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 0.2 |
1.7 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.2 |
1.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.2 |
0.2 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
2.4 |
GO:0038129 |
ERBB3 signaling pathway(GO:0038129) |
| 0.2 |
2.2 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.2 |
4.5 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.2 |
0.9 |
GO:0009608 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.2 |
2.0 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.2 |
1.4 |
GO:1902959 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.2 |
0.7 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.2 |
0.2 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.2 |
0.5 |
GO:1902688 |
regulation of NAD metabolic process(GO:1902688) |
| 0.2 |
0.7 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.2 |
1.4 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 |
0.2 |
GO:1903659 |
complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.2 |
0.3 |
GO:0051135 |
positive regulation of NK T cell activation(GO:0051135) |
| 0.2 |
0.2 |
GO:0033088 |
regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.2 |
0.5 |
GO:0060503 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.2 |
1.0 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.5 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.2 |
0.8 |
GO:0002357 |
defense response to tumor cell(GO:0002357) |
| 0.2 |
0.2 |
GO:1903935 |
response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.2 |
0.6 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.2 |
0.3 |
GO:0051799 |
negative regulation of hair follicle development(GO:0051799) |
| 0.2 |
0.3 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.2 |
0.6 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 |
0.8 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 |
0.5 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
2.9 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 |
1.7 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
0.5 |
GO:1901899 |
positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 0.2 |
0.3 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.2 |
0.3 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.2 |
1.6 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.2 |
0.5 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.2 |
0.6 |
GO:0002238 |
response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 0.2 |
0.3 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.2 |
0.6 |
GO:0003169 |
coronary vein morphogenesis(GO:0003169) |
| 0.2 |
0.5 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.2 |
0.2 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.2 |
0.2 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.2 |
4.7 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 |
2.0 |
GO:1900625 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 |
0.5 |
GO:1904604 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.2 |
0.8 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 |
1.8 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
1.0 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.6 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
4.1 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
0.3 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
1.2 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
0.4 |
GO:0050705 |
regulation of interleukin-1 alpha secretion(GO:0050705) |
| 0.1 |
1.1 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.4 |
GO:0060739 |
mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.1 |
1.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.6 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
0.4 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.1 |
0.8 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.4 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.3 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.1 |
0.7 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.6 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
0.4 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.6 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.4 |
GO:2000329 |
peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.1 |
1.1 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
0.5 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.1 |
1.2 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.1 |
0.3 |
GO:0042253 |
granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
| 0.1 |
0.3 |
GO:0032499 |
detection of peptidoglycan(GO:0032499) |
| 0.1 |
0.4 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.1 |
0.3 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.1 |
0.3 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.1 |
1.7 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.3 |
GO:2000724 |
positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.1 |
0.4 |
GO:0035732 |
nitric oxide storage(GO:0035732) |
| 0.1 |
0.5 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.7 |
GO:0071727 |
toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.1 |
0.5 |
GO:2000053 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.1 |
0.5 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.1 |
0.3 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.8 |
GO:2000470 |
negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.1 |
0.9 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 |
0.3 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.1 |
2.3 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
2.0 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) |
| 0.1 |
0.4 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 0.1 |
0.5 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
0.4 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.1 |
0.4 |
GO:0018160 |
peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.1 |
0.6 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.1 |
0.8 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 |
0.4 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 0.1 |
0.8 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) |
| 0.1 |
0.3 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.1 |
0.7 |
GO:0019060 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.1 |
GO:1903217 |
regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.1 |
1.2 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.1 |
0.2 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 |
0.2 |
GO:0060584 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.1 |
0.5 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
0.6 |
GO:1901091 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 |
0.2 |
GO:1904435 |
positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
| 0.1 |
0.4 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 |
0.5 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 |
1.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.2 |
GO:0060128 |
corticotropin hormone secreting cell differentiation(GO:0060128) |
| 0.1 |
0.5 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.1 |
1.0 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 |
1.2 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 |
0.5 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.9 |
GO:0042695 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 |
0.6 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
0.2 |
GO:2000077 |
negative regulation of type B pancreatic cell development(GO:2000077) |
| 0.1 |
14.1 |
GO:0070268 |
cornification(GO:0070268) |
| 0.1 |
0.4 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.1 |
0.2 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 |
5.6 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.7 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.1 |
0.3 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.1 |
0.5 |
GO:2000687 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.1 |
0.8 |
GO:0097114 |
NMDA glutamate receptor clustering(GO:0097114) |
| 0.1 |
1.2 |
GO:0098881 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 |
0.5 |
GO:0036079 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 |
0.5 |
GO:0015744 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.1 |
0.6 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.1 |
0.3 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.1 |
1.9 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.1 |
0.3 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.1 |
1.1 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.1 |
0.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
0.9 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.1 |
1.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
4.0 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
0.3 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.1 |
0.8 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 |
0.6 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 |
0.4 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 |
0.5 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.1 |
0.3 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
1.9 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
1.2 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 |
0.1 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.1 |
0.3 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 |
1.3 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.1 |
1.0 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.6 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
0.1 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.1 |
1.3 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.8 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 |
0.8 |
GO:0097012 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.3 |
GO:0001189 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.1 |
0.4 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.1 |
0.4 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 |
0.4 |
GO:1901523 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.1 |
1.5 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.1 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
2.5 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.3 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.1 |
1.1 |
GO:0034351 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 |
0.2 |
GO:1905064 |
negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.1 |
0.4 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.1 |
0.4 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.1 |
0.1 |
GO:0032899 |
regulation of neurotrophin production(GO:0032899) |
| 0.1 |
0.8 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.1 |
3.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.5 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 |
0.3 |
GO:1903033 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.9 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.3 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 |
0.4 |
GO:0050960 |
detection of temperature stimulus involved in thermoception(GO:0050960) negative regulation of establishment of blood-brain barrier(GO:0090212) response to capsazepine(GO:1901594) |
| 0.1 |
0.2 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 |
0.1 |
GO:0018963 |
phthalate metabolic process(GO:0018963) terpene metabolic process(GO:0042214) |
| 0.1 |
0.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.7 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.5 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.2 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.1 |
0.9 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.1 |
0.1 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
0.4 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.1 |
0.7 |
GO:2000321 |
positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.1 |
0.5 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
0.3 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.1 |
0.2 |
GO:0052314 |
phytoalexin metabolic process(GO:0052314) |
| 0.1 |
0.5 |
GO:0009253 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 |
0.5 |
GO:0048165 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.4 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.1 |
0.6 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
1.1 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.1 |
1.2 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 |
0.7 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.7 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.4 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
0.4 |
GO:0006238 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 |
0.5 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.1 |
0.2 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
0.9 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
1.7 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.3 |
GO:0036304 |
umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 0.1 |
0.9 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.4 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 |
0.4 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
2.1 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
0.5 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.1 |
0.1 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.1 |
0.4 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
0.3 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.1 |
0.3 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.1 |
1.0 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.3 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
2.2 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.3 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.1 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.1 |
0.8 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.1 |
0.5 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
1.7 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.5 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 |
0.5 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
1.4 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.1 |
0.5 |
GO:0052697 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.1 |
0.2 |
GO:0061590 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.1 |
0.9 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.2 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.1 |
0.6 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.4 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.1 |
1.5 |
GO:0003374 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 |
0.9 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.8 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
0.1 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.1 |
0.1 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.1 |
0.5 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
1.2 |
GO:0035247 |
peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 |
0.1 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.1 |
0.2 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.1 |
0.2 |
GO:0051885 |
anagen(GO:0042640) regulation of anagen(GO:0051884) positive regulation of anagen(GO:0051885) |
| 0.1 |
0.6 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.2 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.1 |
0.9 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.2 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.1 |
0.2 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.1 |
0.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.1 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 0.1 |
0.2 |
GO:1901538 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
0.5 |
GO:0033216 |
ferric iron import(GO:0033216) |
| 0.1 |
0.5 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
0.3 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
0.7 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.1 |
0.4 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
0.5 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.1 |
0.1 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.1 |
0.2 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.1 |
0.6 |
GO:1902661 |
positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.1 |
0.2 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.1 |
0.2 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.1 |
0.5 |
GO:0019640 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
0.2 |
GO:0019470 |
4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 |
0.5 |
GO:1901315 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
1.1 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.1 |
1.5 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.1 |
0.5 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.1 |
1.0 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.1 |
0.4 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
1.0 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.3 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
0.3 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.2 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 |
0.9 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.3 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.1 |
5.8 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 |
0.2 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.6 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.4 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.1 |
0.3 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.6 |
GO:0070255 |
regulation of mucus secretion(GO:0070255) |
| 0.1 |
0.3 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.3 |
GO:1904058 |
positive regulation of gastric acid secretion(GO:0060454) positive regulation of sensory perception of pain(GO:1904058) |
| 0.1 |
0.6 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.1 |
0.3 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.1 |
0.6 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.1 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.1 |
0.4 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.6 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.1 |
0.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.2 |
GO:0072708 |
response to sorbitol(GO:0072708) |
| 0.1 |
0.7 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
0.3 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.1 |
0.4 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.2 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.1 |
1.4 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
0.1 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.1 |
0.6 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.1 |
0.1 |
GO:0043382 |
positive regulation of memory T cell differentiation(GO:0043382) |
| 0.1 |
0.4 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.1 |
GO:0002752 |
cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.1 |
0.1 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.1 |
0.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
1.1 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.1 |
0.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 |
0.1 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.1 |
0.3 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.2 |
GO:0075732 |
viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.1 |
1.0 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.2 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.3 |
GO:0093001 |
glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 |
0.8 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.1 |
1.0 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.1 |
GO:0070055 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 |
0.1 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.1 |
0.3 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.1 |
0.1 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.1 |
0.5 |
GO:0002911 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 |
0.1 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
0.6 |
GO:0045188 |
regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.1 |
0.1 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.1 |
0.2 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.1 |
0.3 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.1 |
0.6 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 |
0.2 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.4 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.1 |
1.0 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.1 |
GO:0048320 |
axial mesoderm morphogenesis(GO:0048319) axial mesoderm formation(GO:0048320) |
| 0.1 |
0.7 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.5 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
0.6 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.2 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.3 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 |
1.0 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.2 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 |
0.1 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
0.2 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
1.3 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.1 |
0.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.2 |
GO:0000451 |
rRNA 2'-O-methylation(GO:0000451) |
| 0.1 |
0.4 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.1 |
0.1 |
GO:0060995 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.1 |
0.2 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.1 |
0.3 |
GO:0048880 |
sensory system development(GO:0048880) |
| 0.1 |
0.8 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
0.4 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 |
0.2 |
GO:0033133 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.2 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.1 |
0.1 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.1 |
0.5 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.1 |
GO:0051941 |
regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.1 |
0.7 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.2 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
0.1 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.1 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.1 |
0.8 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.1 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
0.2 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.5 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
1.1 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.1 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 |
0.1 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 |
0.5 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 |
0.8 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.8 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 |
0.1 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.8 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.1 |
0.4 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.1 |
0.2 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 |
0.3 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.8 |
GO:0032925 |
regulation of activin receptor signaling pathway(GO:0032925) |
| 0.1 |
2.0 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 |
0.2 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 |
0.4 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
0.2 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.3 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.1 |
0.4 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.1 |
0.7 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.1 |
0.2 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.2 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.1 |
0.3 |
GO:0002396 |
MHC protein complex assembly(GO:0002396) |
| 0.1 |
0.2 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.1 |
0.1 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.1 |
0.1 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 |
0.9 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.1 |
0.5 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
0.3 |
GO:0044800 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.1 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 0.1 |
3.4 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.2 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) |
| 0.1 |
0.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.3 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.2 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.6 |
GO:0016553 |
base conversion or substitution editing(GO:0016553) |
| 0.1 |
0.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.5 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.1 |
0.7 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.1 |
0.1 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.1 |
0.1 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.2 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 |
0.4 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.1 |
0.2 |
GO:0036047 |
protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.1 |
0.3 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.1 |
0.6 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.1 |
0.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.3 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.1 |
0.2 |
GO:1901628 |
positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
| 0.1 |
0.2 |
GO:1902462 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.7 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.1 |
0.6 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.4 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
1.1 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
0.2 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.1 |
GO:0015801 |
aromatic amino acid transport(GO:0015801) |
| 0.1 |
0.3 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.1 |
0.6 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
0.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 |
0.4 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 |
0.6 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.2 |
GO:0003409 |
optic cup structural organization(GO:0003409) |
| 0.1 |
0.1 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.1 |
0.2 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.1 |
0.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.3 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 |
0.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.2 |
GO:0009753 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 |
0.1 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 |
0.2 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.3 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.4 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
0.2 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.1 |
0.1 |
GO:0001839 |
neural plate morphogenesis(GO:0001839) |
| 0.1 |
0.2 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 |
1.6 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
0.9 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.2 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 |
0.6 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.6 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.1 |
0.4 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.5 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.1 |
0.9 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.1 |
0.2 |
GO:0018011 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.0 |
0.1 |
GO:0060133 |
somatotropin secreting cell development(GO:0060133) |
| 0.0 |
0.1 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.0 |
0.0 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.0 |
0.1 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.0 |
0.2 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.0 |
0.0 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.1 |
GO:0010932 |
macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
| 0.0 |
0.0 |
GO:1900756 |
protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.0 |
0.1 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.0 |
0.0 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.0 |
0.3 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 |
0.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.0 |
0.3 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.1 |
GO:1903004 |
regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 0.0 |
0.6 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.2 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 0.0 |
0.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.1 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.0 |
0.2 |
GO:0072093 |
metanephric renal vesicle formation(GO:0072093) |
| 0.0 |
0.1 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.0 |
0.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 |
0.2 |
GO:0010819 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.0 |
0.5 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.0 |
0.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.1 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.0 |
0.2 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.0 |
1.1 |
GO:0014733 |
regulation of skeletal muscle adaptation(GO:0014733) |
| 0.0 |
0.1 |
GO:1905065 |
regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.0 |
0.4 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.0 |
0.2 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.0 |
0.2 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
| 0.0 |
0.0 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.0 |
0.2 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.0 |
0.5 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
0.1 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 |
0.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.1 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.0 |
0.4 |
GO:1901318 |
negative regulation of sperm motility(GO:1901318) |
| 0.0 |
0.0 |
GO:0032692 |
negative regulation of interleukin-1 production(GO:0032692) |
| 0.0 |
0.0 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.0 |
0.1 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.0 |
0.2 |
GO:0021776 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.0 |
0.4 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.0 |
0.0 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.0 |
0.3 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.0 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.5 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.4 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.0 |
0.3 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.0 |
0.2 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.0 |
0.2 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.0 |
0.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.3 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.3 |
GO:0010578 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.5 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.7 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
1.1 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.1 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.0 |
0.0 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.0 |
0.1 |
GO:0070243 |
regulation of thymocyte apoptotic process(GO:0070243) |
| 0.0 |
0.3 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.0 |
0.4 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.0 |
0.0 |
GO:0032765 |
lymphotoxin A production(GO:0032641) positive regulation of mast cell cytokine production(GO:0032765) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.0 |
0.1 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.0 |
0.6 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.6 |
GO:1904871 |
regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.0 |
1.0 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.3 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.1 |
GO:0035627 |
ceramide transport(GO:0035627) |
| 0.0 |
0.1 |
GO:1990036 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 0.0 |
0.3 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.1 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.0 |
0.3 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.0 |
0.1 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 0.0 |
0.5 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
1.4 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.1 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 |
0.5 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 |
0.0 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.0 |
0.0 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.0 |
0.3 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.0 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.0 |
0.3 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.0 |
0.1 |
GO:0071504 |
cellular response to heparin(GO:0071504) |
| 0.0 |
0.0 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.0 |
0.1 |
GO:1903764 |
regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.0 |
0.5 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 |
1.5 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.0 |
1.5 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 |
1.2 |
GO:0071404 |
cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.0 |
0.2 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.1 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.0 |
0.0 |
GO:0033076 |
isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.0 |
0.1 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.0 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.0 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 |
0.1 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.0 |
0.1 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.2 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.0 |
GO:0009726 |
detection of endogenous stimulus(GO:0009726) |
| 0.0 |
0.4 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.7 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.2 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.2 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.0 |
0.1 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.0 |
0.1 |
GO:0051464 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.0 |
0.5 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.0 |
1.3 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.1 |
GO:0043697 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 |
0.2 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.2 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.0 |
0.4 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 |
0.0 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 0.0 |
0.3 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.0 |
0.4 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.2 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.0 |
0.3 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.0 |
0.1 |
GO:0071962 |
mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.0 |
1.0 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.5 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.0 |
0.1 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.0 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.0 |
0.1 |
GO:1903977 |
positive regulation of glial cell migration(GO:1903977) |
| 0.0 |
0.1 |
GO:1903660 |
regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.0 |
0.1 |
GO:0000915 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.0 |
0.2 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.0 |
0.0 |
GO:0050711 |
negative regulation of interleukin-1 secretion(GO:0050711) |
| 0.0 |
0.3 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.3 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.0 |
0.4 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.9 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.0 |
0.1 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 |
0.5 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:0035048 |
splicing factor protein import into nucleus(GO:0035048) |
| 0.0 |
0.2 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
1.1 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.0 |
0.1 |
GO:1904044 |
response to aldosterone(GO:1904044) cellular response to aldosterone(GO:1904045) |
| 0.0 |
0.1 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.1 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.0 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.9 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.4 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.0 |
0.1 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
0.2 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.0 |
0.3 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.0 |
0.3 |
GO:1902571 |
regulation of serine-type endopeptidase activity(GO:1900003) regulation of serine-type peptidase activity(GO:1902571) |
| 0.0 |
0.0 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.1 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.0 |
1.4 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.0 |
0.8 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.2 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.0 |
0.5 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.5 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.0 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.4 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.8 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.0 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
0.2 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.0 |
0.1 |
GO:2000434 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.0 |
0.1 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.0 |
6.9 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.2 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 |
0.2 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.2 |
GO:2000848 |
positive regulation of corticosteroid hormone secretion(GO:2000848) |
| 0.0 |
0.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 |
0.2 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) regulation of rRNA processing(GO:2000232) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.5 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 |
0.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.1 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.0 |
0.2 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.0 |
0.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.4 |
GO:0014854 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) |
| 0.0 |
0.2 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.0 |
0.1 |
GO:0072138 |
cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.0 |
0.2 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 |
0.1 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.0 |
0.2 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
2.2 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.3 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.0 |
0.1 |
GO:1903823 |
regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.0 |
0.1 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.0 |
0.0 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.0 |
0.2 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
| 0.0 |
0.3 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.4 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.4 |
GO:0032727 |
positive regulation of interferon-alpha production(GO:0032727) |
| 0.0 |
0.1 |
GO:1901877 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
0.2 |
GO:0042791 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.2 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.3 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.2 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) |
| 0.0 |
0.1 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.0 |
0.1 |
GO:0070202 |
regulation of establishment of protein localization to chromosome(GO:0070202) |
| 0.0 |
0.2 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.0 |
0.1 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 |
0.2 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.0 |
0.1 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.0 |
0.2 |
GO:2000870 |
regulation of progesterone secretion(GO:2000870) |
| 0.0 |
0.2 |
GO:0090493 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.0 |
0.4 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.3 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.0 |
0.1 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.0 |
0.0 |
GO:0010840 |
regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.0 |
0.1 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.0 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
1.1 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.0 |
0.1 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
0.1 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.0 |
0.5 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.2 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.0 |
0.3 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 |
0.1 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.0 |
0.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.0 |
0.1 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.0 |
0.1 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 |
0.1 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.0 |
0.1 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.0 |
0.1 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.1 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.0 |
0.1 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 |
0.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.0 |
0.1 |
GO:0019364 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.0 |
0.0 |
GO:0003064 |
regulation of heart rate by hormone(GO:0003064) |
| 0.0 |
0.1 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.0 |
0.1 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 |
0.0 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.0 |
0.3 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.0 |
0.0 |
GO:1901374 |
acetate ester transport(GO:1901374) |
| 0.0 |
0.1 |
GO:2000553 |
positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.0 |
0.1 |
GO:2000586 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 0.0 |
0.3 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.0 |
0.1 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.0 |
0.1 |
GO:0048617 |
embryonic foregut morphogenesis(GO:0048617) |
| 0.0 |
0.2 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.0 |
0.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.1 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 |
0.1 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.0 |
0.1 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 0.0 |
0.4 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.2 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.1 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.0 |
0.4 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.7 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.1 |
GO:1901993 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.0 |
0.2 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.0 |
0.1 |
GO:1901836 |
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
| 0.0 |
0.1 |
GO:2000501 |
regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 |
0.3 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.1 |
GO:0034769 |
basement membrane disassembly(GO:0034769) |
| 0.0 |
0.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.0 |
0.3 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.2 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.0 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.4 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.2 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.3 |
GO:0016446 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.3 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
0.1 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.0 |
0.0 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.0 |
0.5 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.2 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.0 |
0.2 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.0 |
0.1 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.0 |
0.1 |
GO:0006524 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.0 |
0.1 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
1.3 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.1 |
GO:0070103 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
| 0.0 |
0.0 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.0 |
0.2 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.2 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
0.2 |
GO:0017182 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.0 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 |
0.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.2 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.2 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.0 |
0.2 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.0 |
0.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.0 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.0 |
0.2 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.3 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.0 |
0.1 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.0 |
0.2 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.0 |
GO:0033563 |
spinal cord ventral commissure morphogenesis(GO:0021965) dorsal/ventral axon guidance(GO:0033563) |
| 0.0 |
0.6 |
GO:0051904 |
pigment granule transport(GO:0051904) |
| 0.0 |
0.1 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 0.0 |
0.1 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.0 |
0.0 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.0 |
0.0 |
GO:0015847 |
putrescine transport(GO:0015847) |
| 0.0 |
0.0 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.0 |
0.1 |
GO:0002727 |
natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.0 |
0.1 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.0 |
0.1 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 0.0 |
0.3 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.1 |
GO:0042946 |
glucoside transport(GO:0042946) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.1 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
| 0.0 |
0.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.1 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.0 |
0.1 |
GO:1901162 |
primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
0.7 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.1 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.0 |
0.1 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.0 |
0.1 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.0 |
0.2 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.4 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.0 |
0.0 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.0 |
0.4 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.0 |
0.5 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.0 |
0.0 |
GO:1903094 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.0 |
0.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.1 |
GO:1902474 |
regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
0.8 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.1 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.2 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.0 |
0.1 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.0 |
0.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.0 |
2.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.6 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.0 |
0.2 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.0 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) |
| 0.0 |
0.6 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
0.1 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.0 |
0.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.0 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.0 |
GO:0036378 |
calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.0 |
0.2 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.1 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.0 |
1.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.0 |
GO:0009820 |
alkaloid metabolic process(GO:0009820) |
| 0.0 |
0.1 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 |
0.0 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.0 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.0 |
0.2 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.1 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.0 |
0.3 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.0 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 |
0.4 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 |
0.1 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.0 |
0.0 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
0.5 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.2 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
| 0.0 |
0.1 |
GO:0003218 |
cardiac left ventricle formation(GO:0003218) |
| 0.0 |
0.1 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.0 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.0 |
0.0 |
GO:0034699 |
response to luteinizing hormone(GO:0034699) |
| 0.0 |
0.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.0 |
0.1 |
GO:0007210 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
| 0.0 |
0.1 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.0 |
0.8 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.0 |
0.2 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.0 |
0.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.0 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.0 |
0.2 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 |
0.1 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.0 |
0.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 |
0.0 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.0 |
0.1 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.0 |
0.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.0 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.0 |
0.1 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.1 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.0 |
0.0 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.0 |
GO:1904953 |
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.0 |
0.1 |
GO:0032277 |
negative regulation of gonadotropin secretion(GO:0032277) |
| 0.0 |
0.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.0 |
GO:0086028 |
bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.0 |
0.1 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.0 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.0 |
0.1 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.0 |
0.0 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 |
0.0 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.1 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 |
0.1 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.1 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.0 |
0.1 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 |
0.2 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.5 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.1 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.0 |
GO:0072108 |
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
| 0.0 |
0.1 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.1 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
0.0 |
GO:0098759 |
response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.0 |
0.2 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.0 |
0.0 |
GO:0036166 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.0 |
0.1 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.0 |
0.0 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 |
0.1 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.0 |
0.2 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.0 |
0.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.0 |
GO:0071402 |
cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.0 |
0.2 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.0 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 |
0.0 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.0 |
0.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 |
0.0 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.0 |
0.0 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.0 |
0.0 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.0 |
0.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 |
0.0 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.0 |
0.3 |
GO:0043039 |
tRNA aminoacylation(GO:0043039) |
| 0.0 |
0.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.0 |
0.2 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.3 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.1 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.0 |
0.0 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.0 |
0.0 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 |
0.0 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.0 |
0.1 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.1 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.0 |
0.0 |
GO:1903542 |
epidermal growth factor catabolic process(GO:0007174) negative regulation of exosomal secretion(GO:1903542) |
| 0.0 |
0.1 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 |
0.4 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.0 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.0 |
0.3 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.0 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.0 |
0.1 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.0 |
0.1 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.0 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.0 |
0.0 |
GO:0031635 |
adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
| 0.0 |
0.0 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.1 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.0 |
0.3 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.0 |
0.1 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.0 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.0 |
0.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.2 |
GO:0097034 |
mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.0 |
0.1 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
0.0 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.0 |
0.1 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.0 |
0.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.0 |
0.1 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
0.0 |
GO:1903679 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.0 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.0 |
0.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.2 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.4 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.0 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.0 |
0.0 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.0 |
0.2 |
GO:1901663 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
